Cervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statement Review
| Authors: | Girda, E.; Randall, L. M.; Chino, F.; Monk, B. J.; Farley, J. H.; O'Cearbhaill, R. E. |
| Review Title: | Cervical cancer treatment update: A Society of Gynecologic Oncology clinical practice statement |
| Abstract: | Cervical cancer is the most commonly diagnosed gynecologic cancer worldwide. Although the incidence has declined with increased screening and higher uptake of human papillomavirus (HPV) vaccination in high-income countries, this disease remains the second highest cause of cancer mortality among women in low- and middle-income countries. In this clinical practice statement, we describe therapies for cervical cancer by treatment setting, as well as quality of life, financial toxicity, and disparities associated with this disease. In addition to chemotherapy and radiation, therapeutic strategies for cervical cancer include immune checkpoint blockade, antiangiogenics, and antibody-drug conjugates. Optimal treatment for recurrent cervical cancer remains an area of unmet need, necessitating further exploration of rational and innovative treatment approaches, including cell and immune-based therapies. Importantly, development of effective therapies for cervical cancer must incorporate strategies to ensure universal equitable access to HPV vaccination, screening, and treatment. Important consequences of the disease and treatment that impact quality of life must also be addressed. Patients with cervical cancer are at increased risk for financial toxicity, which can lead to downstream detrimental effects on physical, financial, and career outcomes. Underrepresentation of racial and ethnic minorities in gynecologic oncology clinical trials highlights the urgent need for collaborative and focused initiatives to bridge the significant divide and alleviate inequalities in the prevention and treatment of cervical cancer. © 2023 Elsevier Inc. |
| Keywords: | treatment; cervical cancer; society of gynecologic oncology |
| Journal Title: | Gynecologic Oncology |
| Volume: | 179 |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-12-01 |
| Start Page: | 115 |
| End Page: | 122 |
| Language: | English |
| DOI: | 10.1016/j.ygyno.2023.10.017 |
| PROVIDER: | scopus |
| PUBMED: | 37980766 |
| DOI/URL: | |
| Notes: | The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Corresponding author is MSK author: Roisin E. O'Cearbhaill -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
272O'Cearbhaill -
224Chino
Related MSK Work